Neural computational prediction of oral drug absorption based on CODES 2D descriptors

European Journal of Medicinal Chemistry

Volumn 45, Issue 3, 2010, Pages 930-940

  Guerra, A ^a   Campillo, N E ^a   Paez J A ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

ADMET; CODES; Neural Network; Oral Absorption; QSPR

Indexed keywords

ANIMAL TESTING ALTERNATIVE; ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER MODEL; CORRELATIONAL STUDY; DRUG ABSORPTION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; METHODOLOGY; NONLINEAR SYSTEM; ORAL DRUG ADMINISTRATION; PROGRAM DEVELOPMENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEIVER OPERATING CHARACTERISTIC;

ADMINISTRATION, ORAL; HUMANS; MODELS, CHEMICAL; NEURAL NETWORKS (COMPUTER); PERMEABILITY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TECHNOLOGY, PHARMACEUTICAL;

EID: 76049101784     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.11.034     Document Type: Article

References (70)

1. Van de Waterbeemd H., and Gifford E. ADMET in silico modelling: towards prediction paradise?. Nat Rev Drug Discov 2 3 (2003) 192-204
2. Hodgson J. ADMET - turning chemicals into drugs. Nat Biotechnol 19 8 (2001) 722-726
3. REACH, http://europea.en.int/comm/enterprise/reach/index_en.htm.
4. Clemedson C., Kolman A., and Forsby A. The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests. Altern Lab Anim 35 1 (2007) 33-38
5. Mohan C.G., Gandhi T., Garg D., and Shinde R. Computer-assisted methods in chemical toxicity prediction. Mini Rev Med Chem 7 5 (2007) 499-507
6. Linnankoski J., Makela J.M., Ranta V.P., Urtti A., and Yliperttula M. Computational prediction of oral drug absorption based on absorption rate constants in humans. J Med Chem 49 12 (2006) 3674-3681
7. Hou T., Wang J., Zhang W., Wang W., and Xu X. Recent Advances in Computational Prediction of Drug Absorption and Permeability in Drug Discovery. Curr. Med. Chem. 13 22 (2006) 2653-2667
8. Butina D., Segall M.D., and Frankcombe K. Predicting ADME properties in silico: methods and models. Drug Discov Today 7 11 Suppl (2002) S83-S88
9. Ruiz-Garcia A., Bermejo M., Moss A., and Casabo V. Pharmacokinetics in drug discovery. J Pharm Sci 97 2 (2008) 654-690
10. Norinder U., and Bergstrom C.A. Prediction of ADMET Properties. ChemMedChem 1 9 (2006) 920-937
11. Johnson S.R., and Zheng W. Recent progress in the computational prediction of aqueous solubility and absorption. Aaps J 8 1 (2006) E27-E40
12. Xia C.D., Yang J.J., and balani S.K. Drug Transporters in Drug Disposition, Drug Interactions, and Drug Resistance. In: Zhang D.Z., Zhu M., and Humpherys W.G. (Eds). Drug metabolism in drug design and development (2007), Wiley-VCH
13. Van De Waterbeemd H., Lennernds H., Artursson P., Mannhold R., Kubinyi H., and Folkers G. Drug bioavailability: estimation of solubility, permeability, absorption and bioavailability (2006), Wiley-VCH
14. Irvine J.D., Takahashi L., Lockhart K., Cheong J., Tolan J.W., Selick H.E., and Grove J.R. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. J Pharm Sci 88 1 (1999) 28-33
15. Hidalgo I.J., Raub T.J., and Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 3 (1989) 736-749
16. Cho M.J., Thompson D.P., Cramer C.T., Vidmar T.J., and Scieszka J.F. The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier. Pharm Res 6 1 (1989) 71-77
17. Matsson P., Bergstrom C.A., Nagahara N., Tavelin S., Norinder U., and Artursson P. Exploring the role of different drug transport routes in permeability screening. J Med Chem 48 2 (2005) 604-613
18. Nagahara N., Tavelin S., and Artursson P. Contribution of the paracellular route to the pH-dependent epithelial permeability to cationic drugs. J Pharm Sci 93 12 (2004) 2972-2984
19. Avdeef A. The rise of PAMPA. Expert Opin Drug Metab Toxicol 1 2 (2005) 325-342
20. Hidalgo I.J. Assessing the absorption of new pharmaceuticals. Curr Top Med Chem 1 5 (2001) 385-401
21. Kansy M., Senner F., and Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41 7 (1998) 1007-1010
22. Lipinski C. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 44 1 (2000) 235-249
23. Lipinski C., Lombardo F., Dominy B., and Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery. Adv Drug Deliv Rev 23 (1997) 3-25
24. Campillo N.E., and Páez J.A. In Silico ADME Front. Drug Des. Discov. 4 (2009) 291-332
25. Ekins S., Mestres J., and Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol 152 1 (2007) 9-20
26. Dokoumetzidis A., Kalantzi L., and Fotaki N. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Expert Opin Drug Metab Toxicol 3 4 (2007) 491-505
27. Mizuno N., Niwa T., Yotsumoto Y., and Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 55 3 (2003) 425-461
28. W.J. Egan, In: Annual review in medicinal chemistry, vol. 42 (Ed.: J. Macor), Elselvier, 2007.
29. Egan W., Merz K., and Baldwin J. Prediction of drug absorption using multivariate statistics. J Med Chem 43 21 (2000) 3867-3877
30. Ekins S., and Rose J. In silico ADME/Tox: the state of the art. J Mol Graph Model 20 4 (2002) 305-309
31. Andrews C., Bennett L., and Yu L. Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship. Pharm Res 17 6 (2000) 639-644
32. Stenberg P., Luthman K., Ellens H., Lee C.P., Smith P.L., Lago A., Elliot J.D., and Artursson P. Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity. Pharm Res 16 (1999) 1520-1526
33. Norinder U., and Oesterberg T. Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices. J Pharm Sci 90 8 (2001) 1076-1085
34. Yoshida F., and Topliss J. QSAR model for drug human oral bioavailability. J Med Chem 43 13 (2000) 2575-2585
35. Ren S., and Lien E. Caco-2 cell permeability vs human gastro-intestinal absorption. Prog. Drug Res. (2000)
36. Oprea T., and Gottfries J. Toward minimalistic modeling of oral drug absorption. J. Mol. Graphics Modell. 17 5-6 (1999) 261-274
37. Sugawara M., Takekuma Y., Yamada H., Kobayashi M., Iseki K., and Miyazaki K. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. J Pharm Sci 87 8 (1998) 960-966
38. van De Waterbeemd H.C., Folkers G., and Raevsky O.A. Estimation of Caco-2 cell permeability using calculated molecular descriptors. QSAR Comb. Sci. 15 6 (2006) 480-490
39. Votano J., Parham M., Hall L., and Kier L. New predictors for several ADME/Tox properties: aqueous solubility, human oral absorption, and Ames genotoxicity using topological descriptors. Mol. Diversity 8 4 (2004) 379-391
40. Niwa T. Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures. J Chem Inf Comput Sci 43 1 (2003) 113-119
41. Yamashita F., Wanchana S., and Hashida M. Quantitative structure/property relationship analysis of Caco-2 permeability using a genetic algorithm-based partial least squares method. J Pharm Sci 91 10 (2002) 2230-2239
42. Wessel M.D., Jurs P.C., Tolan J.W., and Muskal S.M. Prediction of human intestinal absorption of drug compounds from molecular structure. J Chem Inf Comput Sci 38 4 (1998) 726-735
43. Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 88 8 (1999) 815-821
44. Palm K., Luthman K., Ungell A.L., Strandlund G., Beigi F., Lundahl P., and Artursson P. Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J Med Chem 41 27 (1998) 5382-5392
45. Palm K., Stenberg P., Luthman K., and Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res 14 5 (1997) 568-571
46. Palm K., Luthman K., Ungell A.L., Strandlund G., and Artursson P. Correlation of drug absorption with molecular surface properties. J Pharm Sci 85 1 (1996) 32-39
47. Hou T., Wang J., Zhang W., and Xu X. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification. J Chem Inf Model 47 1 (2007) 208-218
48. Zhao Y.H., Le J., Abraham M.H., Hersey A., Eddershaw P.J., Luscombe C.N., Butina D., Beck G., Sherborne B., Cooper I., and Platts J.A. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J Pharm Sci 90 6 (2001) 749-784
49. Klopman G., Stefan L., and Saiakhov R. ADME evaluation 2. A computer model for the prediction of intestinal absorption in humans. Eur J Pharm Sci 17 4-5 (2002) 253-263
50. Cabrera M.A., Bermejo M., Perez M., and Ramos R. TOPS-MODE approach for the prediction of blood-brain barrier permeation. J Pharm Sci 93 7 (2004) 1701-1717
51. Jones R., Connolly P., Klamt A., and Diedenhofen M. Use of surface charges from DFT calculations to predict intestinal absorption. J. Chem. Inf. Model. 45 5 (2005) 1337-1342
52. Guerra A., Paez J., and Campillo N. Artificial neural networks in admet modeling: prediction of blood-brain barrier permeation. QSAR Comb Sci 27 5 (2008) 586
53. http://www.acutetox.org
54. Zmuidinavicius D., Didziapetris R., Japertas P., Avdeef A., and Petrauskas A. Classification structure-activity relations (C-SAR) in prediction of human intestinal absorption. J Pharm Sci 92 3 (2003) 621-633
55. ® v1.0 (revisión 3). Idea original del Prof. Manfred Stud.
56. Liu H.X., Hu R.J., Zhang R.S., Yao X.J., Liu M.C., Hu Z.D., and Fan B.T. The prediction of human oral absorption for diffusion rate-limited drugs based on heuristic method and support vector machine. J Comput Aided Mol Des 19 1 (2005) 33-46
57. Gil C., Dorronsoro I., Castro A., and Martinez A. Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques. Bioorg Med Chem Lett 15 7 (2005) 1919-1921
58. Dorronsoro I., Chana A., Abasolo I., Castro A., Gil C., Stud M., and Martinez A. CODES/Neural network model: a useful tool for in silico prediction of oral absorption and blood-brain barrier permeability of structurally diverse drugs. QSAR Comb Sci 23 2-3 (2004) 89-98
59. Ochoa C., Rodriguez J., Rodriguez M., Chana A., Stud M., Alonso-Villalobos P., and Martinez-Grueiro M.M. Application of neural networks to the study of structure-activity relationships of 6,7-diarylpteridines as nematocides. Med Chem Res 7 9 (1997) 530-545
60. Xue Y., Li Z., Yap C., Sun L., Chen X., and Chen Y. Effect of molecular descriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents. J Chem Inf Comput Sci 44 5 (2004) 1630-1638
61. Sun H. A universal molecular descriptor system for prediction of log P, log S, log BB, and absorption. J Chem Inf Comput Sci 44 2 (2004) 748-757
62. Osterberg T., and Norinder U. Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics. J Chem Inf Comput Sci 40 6 (2000) 1408-1411
63. Ghuloum A.M., Sage C.R., and Jain A.N. Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules. J Med Chem 42 10 (1999) 1739-1748
64. Agatonovic-Kustrin S., Beresford R., and Yusof A. Theoretically-derived molecular descriptors important in human intestinal absorption. J Pharm Biomed Anal 25 2 (2001) 227-237
65. Norinder U., Sjoberg P., and Osterberg T. Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. J Pharm Sci 87 8 (1998) 952-959
66. Deconinck E., Hancock T., Coomans D., Massart D., and Heyden Y. Classification of drugs in absorption classes using the classification and regression trees (CART) methodology. J Pharm Biomed Anal 39 1-2 (2005) 91-103
67. Kohler W. The Task of Gestalt Psychology (1969), Princeton, New Jersey 66-92
68. McClelland J., and Rumelhart D. Foundations. Parallel distributed processing: explorations in the microstructure of cognition vol. 2 (1989), Mass: Bradford Books & MIT Press, Cambridge
69. ®, v3.3., Oxford, Moleculars, Ltd., http://www.oxomol.com.
70. Triballeau N., Acher F., Brabet I., Pin J.P., and Bertrand H.O. Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48 7 (2005) 2534-2547